Dice Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Dice Therapeutics

13/05/2022 21:30

* Dice Therapeutics Inc  DICE.OQ  reported a quarterly
adjusted
loss of 50 cents​​ per share for the quarter ended in March. The
lone analyst forecast for the quarter was for a loss of 54 cents
per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Dice Therapeutics Inc's reported EPS for the quarter was a
loss
of 50 cents​.
    * The mean earnings estimate of analysts had risen by
about 5.3%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Dice Therapeutics Inc shares had fallen by 14.6% this
quarter and lost 35.4% so far this year.
    * The company reported a quarterly loss of $18.59 million.
    * Wall Street's median 12-month price target for Dice
Therapeutics
Inc is $46.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated May 13 at 08:30 p.m.  ​All
figures in US dollars unless otherwise stated